Research Article
Hyperprogressive Disease Caused by PD-1 Inhibitors for the Treatment of Pan-Cancer
Table 3
Association between the KRAS status and HPD for patients with colorectal cancer treated with immunotherapy (, %).
| ||||||||||||||||||||||||||||
HPD: hyperprogressive disease. |